Clinical Trials for Clostridioides Difficile Infection

Find clinical trials for clostridioides difficile infection. Discover research opportunities and treatment options in your area.

21 Active Trials Found

Showing 21 trials on this page

Page 1 of 2

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

NCT ID: NCT06237452

The VE303 clinical trial is studying a new treatment called VE303 to see if it can help prevent repeated infections caused by Clostridioides difficile, often called C. diff. This trial is open to t...

Recruiting

Phase: PHASE3 Type: interventional Locations: Rochester, Minnesota, United States, Kansas City, Kansas, United States +191 more

LMN-201 for Prevention of C. Difficile Infection Recurrence

NCT ID: NCT05330182

This clinical trial is looking at a new medication called LMN-201, which aims to prevent the recurrence of Clostridioides difficile infection (CDI) in patients who have recently been diagnosed and ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Bridgeport, Connecticut, United States, Houston, Texas, United States +17 more

Secondary Prevention of Clostridioides Difficile Using Vancomycin

NCT ID: NCT06979609

This clinical trial is studying whether taking an antibiotic called oral vancomycin can help prevent Clostridioides difficile infections (CDI) from coming back in patients who are re-exposed to sys...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Montreal, Quebec, Canada

A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.

NCT ID: NCT06948461

This clinical trial is testing a new treatment called oral lyophilized fecal microbiota therapy (ORAL-LYO-FMT) to see if it can help people with diarrhea-predominant irritable bowel syndrome (IBS-D...

Not yet recruiting

Phase: PHASE2 Type: interventional

Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients

NCT ID: NCT06306014

This clinical trial is studying a new treatment called EXL01, which is designed to help prevent the recurrence of Clostridioides difficile infection (CDI) in patients who are at high risk for getti...

Recruiting

Phase: PHASE1 Type: interventional Locations: Clermont Ferrand, , France, Lyon, , France +7 more

FMT in Initial CDI

NCT ID: NCT05257538

This clinical trial is studying a treatment called fecal microbiota transfer (FMT), which involves using a retention enema to help patients recover from their first episode of Clostridioides diffic...

Recruiting

Phase: NA Type: interventional Locations: Turku, , Finland

Evaluation of GeoHAI Implementation

NCT ID: NCT05612672

This clinical trial is studying a new computer application that uses mapping and geographic information to help hospitals better understand and prevent infections that patients can get while being ...

Recruiting

Phase: NA Type: interventional Locations: Columbus, Ohio, United States

Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy

NCT ID: NCT06884748

This clinical trial is looking at whether a medication called Ursodeoxycholic Acid (UDCA) can help prevent the return of Clostridioides difficile (C. diff) colitis, a serious intestinal infection, ...

Not yet recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Milwaukee, Wisconsin, United States

Prevention of Clostridium Difficile Infections Using Lactobacillus Plantarum 299v Strain in Nephrology and Transplantation Department

NCT ID: NCT06859437

This clinical trial is looking at whether a specific probiotic called Lactobacillus plantarum 299v can help prevent Clostridium difficile infections (CDI) in patients who are hospitalized and recei...

Recruiting

Phase: NA Type: interventional Locations: Poland, Silesia, Poland

CMTS0929 for Clostridioides Difficile Infection

NCT ID: NCT06836427

This clinical trial is studying a new treatment called CMTS0929 for patients suffering from Clostridioides difficile infection (CDI), which is a serious type of gut infection. The goal of this stud...

Not yet recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Nanjing, Jiangsu, China

Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients with Inflammatory Bowel Disease

NCT ID: NCT06799039

This clinical trial is looking at a substance called xylitol, which is a type of sugar alcohol, to see if it can help patients with Inflammatory Bowel Disease (IBD) who also have a Clostridioides d...

Not yet recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Boston, Massachusetts, United States

Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence

NCT ID: NCT05266807

This clinical trial is studying a treatment called fecal microbiota transplantation (FMT) for patients with Clostridioides difficile infection (CDI). CDI can cause severe diarrhea and is often toug...

Recruiting

Phase: PHASE3 Type: interventional Locations: Lausanne, Vaud, Switzerland

Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients with Inflammatory Bowel Disease

NCT ID: NCT06794944

This clinical trial is studying two antibiotics, fidaxomicin and vancomycin, to see which one works better for treating a type of infection called C. difficile in patients with inflammatory bowel d...

Not yet recruiting

Phase: PHASE4 Type: interventional Locations: Boston, Massachusetts, United States

Study of Clostridioides Difficile in Infants

NCT ID: NCT06788769

This clinical trial is studying Clostridioides difficile infection (CDI) in infants, which is becoming a more common health issue for children under two years old. The researchers want to understan...

Recruiting

Type: observational Locations: Hangzhou, Zhejiang, China

Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)

NCT ID: NCT04305769

The Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT) trial is studying whether a supplement called alanyl-glutamine can help patients who have a C. difficile infection (CDI), a typ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Roanoke, Virginia, United States, Charlottesville, Virginia, United States

Xylitol Use for Decolonization of C. Difficile in Patients With IBD

NCT ID: NCT05852587

This clinical trial, titled "Xylitol Use for Decolonization of C. Difficile in Patients With IBD," is exploring whether xylitol, a natural sugar substitute, can help remove the bacteria Clostridioi...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States

Lyophilized Fecal Microbiome Transfer vs. Vancomycin Monotherapy for Primary Clostridioides Difficile Infection

NCT ID: NCT05709184

This clinical trial is studying a new treatment for Clostridioides difficile infection (CDI), a type of infection that can cause severe diarrhea. Researchers want to find out if a treatment called ...

Recruiting

Phase: NA Type: interventional Locations: Edmonton, , Canada, Debrecen, , Hungary +4 more

Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections

NCT ID: NCT03895593

This clinical trial is studying a treatment called fecal microbiota transplantation (FMT) for patients who have severe intestinal infections that haven’t improved with standard treatments. Specific...

Recruiting

Type: observational Locations: Nanjing, Jiangsu, China

Washed Microbiota Transplantation for Clostridioides Difficile Infection

NCT ID: NCT06106698

This clinical trial is studying a treatment called washed microbiota transplantation (WMT) for people who have Clostridioides Difficile Infection (CDI), which is a serious infection that can cause ...

Recruiting

Type: observational Locations: Nanjing, Jiangsu, China

Clostridioides Difficile Colonisation

NCT ID: NCT05693077

This clinical trial is studying a type of bacteria called non-toxigenic Clostridioides difficile (NTCD) to see if it can safely colonize the intestines of healthy volunteers. Researchers want to un...

Recruiting

Phase: PHASE1 Type: interventional Locations: Leiden, , Netherlands, Leiden, , Netherlands

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions